e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Immunopathological mechanisms of lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Levels of CD4CD25 T regulatory cells in bronchial mucosa and peripheral blood of chronic obstructive pulmonary disease indicate involvement of autoimmunity mechanisms
V. Sileikiene (Vilnius, Lithuania), A. Laurinaviciene (Vilnius, Lithuania), D. Lesciute-Krilaviciene (Vilnius, Lithuania), L. Jurgauskiene (Vilnius, Lithuania), J. Norkuniene (Vilnius, Lithuania), A. Laurinavicius (Vilnius, Lithuania)
Source:
International Congress 2019 – Immunopathological mechanisms of lung disease
Session:
Immunopathological mechanisms of lung disease
Session type:
Thematic Poster
Number:
4102
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Sileikiene (Vilnius, Lithuania), A. Laurinaviciene (Vilnius, Lithuania), D. Lesciute-Krilaviciene (Vilnius, Lithuania), L. Jurgauskiene (Vilnius, Lithuania), J. Norkuniene (Vilnius, Lithuania), A. Laurinavicius (Vilnius, Lithuania). Levels of CD4CD25 T regulatory cells in bronchial mucosa and peripheral blood of chronic obstructive pulmonary disease indicate involvement of autoimmunity mechanisms. 4102
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Pulmonary dendritic cells from chronic obstructive pulmonary disease patients suppress lung immune responses through induction of regulatory T cells
Source: Annual Congress 2011 - T-cell subsets
Year: 2011
The role of regulator and effector T lymphocytes in chronic obstructive pulmonary disease and lung cancer
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010
Decreased TCR γδ T lymphocytes in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 85s
Year: 2003
Lung dendritic cells from chronic obstructive pulmonary disease patients induce type 1 T regulatory cells
Source: Annual Congress 2012 - Immunologic mechanisms in COPD and asthma
Year: 2012
Exhausted T lymphocytes in chronic obstructive pulmonary disease: single-cell analysis of human lung tissue
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021
Increased CD4+ T-cell infiltration in bronchial epithelium of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Epithelial networks in the airways
Year: 2007
A high probability of short-range interactions between fibrocytes and CD8+ T cells potentiates the inflammatory response in chronic obstructive pulmonary disease (COPD) lungs
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020
Regulator and effector T lymphocytes in late stages of non small cell lung cancer and chronic obstructive pulmonary disease
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012
Decreased FOXP3 expression in small airways of smokers with COPD
Source: Eur Respir J 2009; 33: 61-67
Year: 2009
High percentage of CD8+ effector T lymphocytes in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002
A high probability of short-range interactions between fibrocytes and CD8 T cells in chronic obstructive pulmonary disease (COPD) lungs
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019
Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema
Source: Eur Respir J 2001; 17: 946-953
Year: 2001
Apoptosis and activation of peripheral blood neutrophils in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 74s
Year: 2001
Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis
Source: Eur Respir J 2016; 48: 1171-1183
Year: 2016
T regulatory cells within inflammatory foci of COPD lungs
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008
STAT4 activation in smokers and patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 78-85
Year: 2004
Role of regulatory T-cells (Tregs) in bacterial infection-induced lung fibrosis exacerbation in mice
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018
Peripheral blood Th17 and Th17/Th2 cells and their association with lung function and biomarkers in asthma-COPD overlap syndrome
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017
Increased regulatory T cells in the blood of patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 659s
Year: 2006
Decreased pulmonary immunoregulatory/suppressor (CD4+CD25+) T-lymphocytes in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 85s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept